New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Read more

Eliquis

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ELIQUIS® (elle-e-kuis) apixaban Consumer Medicine Information What

Read more